NASDAQ ยท Financial Statements

Lycia Therapeutics, Inc. (LYCA) Financial Statements

$29.64 NASDAQ: LYCA Market Cap $1.54B

Full income statement, balance sheet, and cash flow statement for Lycia Therapeutics, Inc. (LYCA), plus valuation and return ratios.

Annual financials are not yet available for this stock.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
LYCA Overview LYCA Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.